Weight Loss Program

West End Salon and Medspa weight loss program uses semaglutide or Tirzepatide. The program begins with an initial consultation with the nurse practitioner, and labs are drawn to ensure all organs are working properly. Medications and supplies are included.

The FDA approved Semaglutide in 2014 for use with Type 2 diabetics to maintain blood sugar levels. During clinical trials, Semaglutide proved it had other benefits, including improved cardiovascular risk, decreased inflammation, decreased appetite, and weight loss. In 2019, Semaglutide was FDA approved for use in patients with a BMI of 30 or greater, or a BMI of 27 and greater with at least one comorbidity, for weight management.

Semaglutide is a glucagon-like peptide-1 receptor agonist. It mimics the action of the incretin GL-1 by increasing the production of insulin. Semaglutide for weight suppresses your appetite and works in the brain’s areas that regulate appetite and food intake. In addition to using Semaglutide, an exercise program and reduced caloric intake will aid in weight loss goals and long-term management.

We also use Tirzepatide in our weight loss program. Tirzepatide, known as Mounjaro, was approved by the FDA in 2022 to treat type 2 diabetes. As with semaglutide, participants in a clinical trial on a 15 mg dose of Tirzepatide experienced a 20% weight loss.On October 6, 2022, the FDA granted Tirzepatide a fast-track review to be used as a treatment for obesity. This designation provides Tirzepatide with a positive way to fill a serious medical need. It is used similarly to semaglutide for weight loss.